{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:08:32Z","timestamp":1790255312391,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007508","name":"Sigurd and Elsa Goljes Memory Foundation","doi-asserted-by":"publisher","award":["LA2025-0024"],"award-info":[{"award-number":["LA2025-0024"]}],"id":[{"id":"10.13039\/501100007508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Stockholm Cancer Society","doi-asserted-by":"publisher","award":["241131"],"award-info":[{"award-number":["241131"]}],"id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004722","name":"Lars Hierta Memorial Foundation","doi-asserted-by":"publisher","award":["FO2024-0399"],"award-info":[{"award-number":["FO2024-0399"]}],"id":[{"id":"10.13039\/501100004722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["23 2700"],"award-info":[{"award-number":["23 2700"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000866","name":"Cardiff University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003514","name":"Kommunfullm\u00e4ktige, Stockholms Stad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omton.2026.201283","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:48:27Z","timestamp":1782863307000},"page":"201283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual targeting of PI3K and FGFR or CDK4\/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-0710","authenticated-orcid":false,"given":"Madeleine","family":"Birgersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Lukoseviciute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania N.","family":"Kostopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dalianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201283_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.omton.2026.201283_bib2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G","article-title":"Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival","volume":"89","author":"Mellin","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omton.2026.201283_bib3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/ijc.20490","article-title":"Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients","volume":"112","author":"Dahlgren","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omton.2026.201283_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.molonc.2007.08.005","article-title":"Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7","volume":"1","author":"Lindquist","year":"2007","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2026.201283_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ijc.24339","article-title":"Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?","volume":"125","author":"N\u00e4sman","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omton.2026.201283_bib6","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201283_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.oraloncology.2013.12.019","article-title":"Epidemiology of HPV-associated oropharyngeal cancer","volume":"50","author":"Pytynia","year":"2014","journal-title":"Oral Oncol."},{"key":"10.1016\/j.omton.2026.201283_bib8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hed.25585","article-title":"Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden","volume":"41","author":"Haeggblom","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.omton.2026.201283_bib9","series-title":"PDQ Oropharyngeal Cancer Treatment","year":"2024"},{"key":"10.1016\/j.omton.2026.201283_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1040-8428(01)00129-9","article-title":"Cancer of the oropharynx","volume":"41","author":"Licitra","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.omton.2026.201283_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/gm453","article-title":"Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors","volume":"5","author":"Lechner","year":"2013","journal-title":"Genome Med."},{"key":"10.1016\/j.omton.2026.201283_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2016.01.003","article-title":"Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation","volume":"57","author":"Tinhofer","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.omton.2026.201283_bib13","doi-asserted-by":"crossref","first-page":"35339","DOI":"10.18632\/oncotarget.15240","article-title":"Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3","volume":"8","author":"Bersani","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2026.201283_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jnci\/djz224","article-title":"PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation","volume":"112","author":"Beaty","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.omton.2026.201283_bib15","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/joim.20088","article-title":"Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer","volume":"297","author":"Zupancic","year":"2025","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.omton.2026.201283_bib16","first-page":"687","article-title":"Alpelisib for PIK3CA-Mutated Advanced Breast Cancer. Reply","volume":"381","author":"Andr\u00e9","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201283_bib17","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1158\/1078-0432.CCR-18-3334","article-title":"Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors","volume":"25","author":"Bahleda","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201283_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.640490","article-title":"Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations","volume":"11","author":"Holzhauser","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2026.201283_bib19","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/v14071372","article-title":"Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4\/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors","volume":"14","author":"Kostopoulou","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2026.201283_bib20","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.21873\/anticanres.16988","article-title":"Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status","volume":"44","author":"Lukoceviciute","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.omton.2026.201283_bib21","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.21873\/anticanres.17822","article-title":"Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell Lines","volume":"45","author":"Birgersson","year":"2025","journal-title":"Anticancer Res."},{"key":"10.1016\/j.omton.2026.201283_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","article-title":"Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy","volume":"164","author":"Mehta","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omton.2026.201283_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","article-title":"Three-dimensional culture systems in cancer research: Focus on tumor spheroid model","volume":"163","author":"Nath","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omton.2026.201283_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110264","article-title":"Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance","volume":"107","author":"Fontoura","year":"2020","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.omton.2026.201283_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.70230","article-title":"Dual PI3K\/AKT and CDK4\/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model","author":"Lukoseviciute","year":"2026","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2026.201283_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207934","article-title":"Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus","volume":"13","author":"Pirotte","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2026.201283_bib27","first-page":"1717","article-title":"Sensitivity of human papillomavirus-positive and -negative oropharyngeal cancer cell lines to ionizing irradiation","volume":"44","author":"Holzhauser","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2026.201283_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genom. Proteom. Bioinform."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:42:45Z","timestamp":1790253765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2950329926001591"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201283","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual targeting of PI3K and FGFR or CDK4\/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201283"}}